Tacita Capital’s Bausch Health BHC Stock Holding History

Tacita Capital’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,940	Closed	-$44K	–	197
2022 Q1	$44K	Buy	1,940 +150	+8%	+$3.67K	0.03%	151
2021 Q4	$49K	Hold	1,790	–	–	0.03%	147
2021 Q3	$50K	Buy	1,790 +190	+12%	+$5.39K	0.03%	140
2021 Q2	$47K	Buy	1,600 +250	+19%	+$7.57K	0.03%	149
2021 Q1	$43K	Buy	+1,350	New	+$39.6K	0.03%	155

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Tacita Capital's BHC Position: Q2 2022 in Review

Tacita Capital sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 1,940 shares — an estimated $44K sold.

Tacita Capital first reported a position in BHC in Q1 2021 and held it in 5 quarters. The position peaked at $50K in Q3 2021. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

Tacita Capital reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
Tacita Capital sold 1,940 Bausch Health shares in Q2 2022, an estimated $44K.
Tacita Capital first reported a position in Bausch Health in Q1 2021 and held it in 5 quarters.
Tacita Capital's Bausch Health position peaked at $50K in Q3 2021.
327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Tacita Capital's 13F filing for Q2 2022, filed 12 Aug 2022.